MiR-221-5p aggravates sepsis-induced myocardial injury by targeting neuropilin-1.
It is indicated that miR-221-5p exacerbates septic cardiomyopathy by negatively regulating NRP1, suggesting that the miR-221-5p/NRP1 pathway could represent a novel therapeutic strategy for sepsis-related heart complications.